JUN 05, 2017 11:59 AM PDT

Mycobacterium Tuberculosis Playing Games with the Immune System

WRITTEN BY: Kara Marker

Mycobacterium tuberculosis (Mtb), a pathogenic species of bacteria that kills nearly two million people worldwide every year. From the University of Southampton, researchers investigate Mtb’s offensive strategies, which often deal with manipulating the immune system to its advantage.

The bacterium that causes tuberculosis -- Mycobacterium tuberculosis (Mtb) -- may disrupt human immune system regulation processes to promote destruction of lung tissue, according to new research published in PLOS Pathogens. Credit: Brace PT, et al. (2017)

 

Researchers hypothesized that Mtb was somehow altering immune regulatory pathways designed to prevent an excessive immune response that can lead to autoimmune disease. Past research showed experts that the bacteria could evade the immune system’s efforts to rid the body of disease, but this newest study is focused on how the body influences the immune system to actively make the disease worse.

"Tuberculosis has co-evolved with humans to become an ultimate pathogen, and we identify a mechanism whereby the bacteria disable the 'brakes' of the immune system to cause lung destruction and spread," explained Patience Grace from the University of Southampton.

By extracting human white blood cells and examining the molecular changes when in contact with Mtb, their suspicions were affirmed. They saw Mtb inhibiting a signaling pathway called PI3K/AKT/mTORC1, which is important for regulating the production of a protein called matrix metalloproteinase-1 (MMP-1). This protein contributes to the remodeling of the lung matrix, and its activity is regulated by the PI3K/AKT/mTORC1 pathway. Overactive MMP-1 can lead to lung tissue damage, which is just what Mtb is looking for. The more vulnerable a person’s lung tissue is, the better Mtb can spread and cause disease.

To confirm that Mtb suppresses the PI3K/AKT/mTORC1 pathway, researchers completed study of gene expression in white blood cells extracted from lung tissue in tuberculosis patients. They saw that expression of an important gene from the PI3K/AKT/mTORC1 pathway was lacking. Additionally, they saw that Mtb increases production of MMP-1 in another way: disrupting another signaling pathway, the MAP kinase-interacting kinase (MNK) pathway

More about tuberculosis:

While tuberculosis is thought of as a pulmonary disease, Mtb bacteria are known to infect other parts of the body, including the central nervous system and bone tissue. The immune response to tuberculosis is largely telling of a person’s fate after infection, which is why the present study is so important for scientists interested in developing the most effective treatments for the disease.

The present study was published in the journal PLOS Pathogens.

Sources: Clinical Microbiology Reviews, University of Southampton

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
NOV 17, 2019
Genetics & Genomics
NOV 17, 2019
Increasing Evidence Shows Narcolepsy is an Autoimmune Illness
Narcolepsy is a chronic sleep disorder impacting as many as 200,000 people in the US, and is thought to often go undiagnosed....
NOV 17, 2019
Immunology
NOV 17, 2019
A Novel Therapeutic Target for a Severe Bacterial Infection
Pseudomonas aeruginosa (Pa) is an opportunistic human pathogen that can cause severe illness and even death in people that are hospitalized or have weakene...
NOV 17, 2019
Immunology
NOV 17, 2019
The C-word. Michael Kinch's new book and the future of Cancer Treatment
The C-word. Dare we say it? Is a cure for cancer within reach?   Professor Michael Kinch https://publichealth.wustl.edu/scholars/michael-s-kinch/ of W...
NOV 17, 2019
Health & Medicine
NOV 17, 2019
Low Number of Vaccine Injury Claims Demonstrate Their Safety
To spread awareness of vaccine safety, New York Times reporters Pam Belluck and Reed Abelson wrote a comprehensive report about vaccine injury claim data....
NOV 17, 2019
Immunology
NOV 17, 2019
Immune Protein Prevents Herpes Spreading to the Brain
An immune protein that was discovered more than two decades ago has been identified as the primary component of a molecular blockade that prevents genital ...
NOV 17, 2019
Genetics & Genomics
NOV 17, 2019
Can CRISPR Replace Antibiotics?
Antibiotic-resistant infections claim around 700,000 lives per year, with estimates saying that this number could swell to 10 million by 2050 (Jacobs: 2019...
Loading Comments...